Items Tagged with 'Perrigo'

ARTICLES

Perrigo acquires European drug supplier for $4.48B

November 6, 2014
| By AP
Perrigo is expanding its reach into Europe by acquiring one of the continent's biggest suppliers of non-prescription medicines in a deal valued at about $4.48 billion. Read More

Perrigo buys over-the-counter lines for $51M

March 10, 2014
Perrigo is expecting a new set of over-the-counter products it has acquired to generate at least $20 million in annual revenue. Read More

Judy Brown grows bottom line

December 30, 2013
Judy Brown can justly take credit for Allegan-based Perrigo Co.’s financial growth spurt. Read More

Irish High Court approves Perrigo-Elan acquisition

December 16, 2013
Perrigo Company of Allegan and Elan Corporation, plc of Dublin have announced that the Irish High Court has approved Perrigo's pending acquisition of Elan. Read More

Perrigo reports record year-end income of $441.9M

August 16, 2013
Allegan-based Perrigo has announced record results for both its fourth quarter of 2013 and the entire fiscal year. Read More

O’Perrigo?

Perrigo is not alone in moving its corporate domicile to Ireland.

August 2, 2013
Perrigo is among many other companies when it comes to deciding to change its legal corporate domicile to Ireland. Read More

Perrigo acquires Elan for $8.6B, incorporates in Ireland

July 29, 2013
DUBLIN — Allegan-based drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion — in a deal that should allow the rapidly growing company to incorporate in Ireland, reduce its tax bill and boost its royalty stream. Read More

Perrigo transfers stock listing to NYSE

May 28, 2013
Perrigo has announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange from the NASDAQ Global Select Market. Read More

Perrigo prescribes marketing campaign for store-brand meds

May 16, 2013
Allegan-based Perrigo has begun what it claims is the first broad marketing and communications campaign to raise consumer awareness of, and confidence in, generic over-the-counter medications sold by major retailers under their own store brands. Read More

Perrigo earns $111.9M in 3Q

May 8, 2013
| By AP
Perrigo reports that its net income slipped 3 percent in the fiscal third quarter on costs related to two acquisitions. Read More